Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors

Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) are a new type of drug for the treatment of diabetes, and they have been proven to have a good hypoglycemic effect. Several lines of clinical evidence have shown that SGLT2 inhibitors can significantly reduce the risks of atherosclerosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Meng, Ran, Zhu, Da-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729105/
https://www.ncbi.nlm.nih.gov/pubmed/33336169
http://dx.doi.org/10.1016/j.cdtm.2020.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729105/
https://www.ncbi.nlm.nih.gov/pubmed/33336169
http://dx.doi.org/10.1016/j.cdtm.2020.07.002

Ejemplares similares